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The core histone tails of the nucleosome are subjected2 Wistar Institute
to a variety of covalent modifications, including acetyla-3601 Spruce Street
tion, phosphorylation, methylation, and ubiquitinationRoom 389
[1, 2]. These posttranslational histone modifications playPhiladelphia, Pennsylvania 19104
a fundamental role in the regulation of transcription,3 Department of Anatomy
mostly by affecting chromatin structure and interactionsUniversity of Birmingham Medical School
of non-histone regulatory factors with chromatin [3–5].Birmingham B15 2TT
Unlike acetylation (for a review, see [6]), the role ofUnited Kingdom
histone methylation is much less clear, although this
modification was first discovered more than 35 years
ago [7]. A direct link between histone methylation and
Summary gene activity was difficult to study because the responsi-
ble enzymes were unknown. However, recently, several
Background: Dynamic changes in the modification pat- enzymes carrying out either arginine or lysine methyla-
tern of histones, such as acetylation, phosphorylation, tion activity have been identified (for a review, see [8,
methylation, and ubiquitination, are thought to provide 9]). Protein arginine (R) methyltransferases (PRMTases)
a code for the correct regulation of gene expression share a highly conserved domain encompassing the
mostly by affecting chromatin structure and interactions methyltransferase activity. Although a broad spectrum
of non-histone regulatory factors with chromatin. Re- of substrates for arginine methylation has been identi-
cent studies have suggested the existence of an inter- fied, including RNA-processing proteins, RNA-trans-
play between histone modifications during transcription. porting proteins, protein phosphatase 2A, and G pro-
The CBP/p300 acetylase and the CARM1 methyltrans- teins [10], only three PRMTases, PRMT1, JPB1 (also
ferase can positively regulate the expression of estro- known as PRMT5), and CARM1 (cofactor-associated
gen-responsive genes, but the existence of a crosstalk arginine [R] methyltransferase 1, also known as PRMT4),
between lysine acetylation and arginine methylation on have been demonstrated to possess histone methyl-
chromatin has not yet been established in vivo. transferase activity [8, 9, 11]. PRMT1 has been shown
Results: By following the in vivo pattern of modifica- to specifically methylate arginine 3 of histone H4 in vivo
tions on histone H3, following estrogen stimulation of [12, 13]. CARM1 was isolated through a yeast two-hybrid
the pS2 promoter, we show that arginine methylation screen searching for proteins that interact with the p160
follows prior acetylation of H3. Within 15 min after estro- nuclear hormone receptor coactivator GRIP1 [14]. Both
gen stimulation, CBP is bound to chromatin, and acet- PRMT1 and CARM1 coactivate nuclear hormone recep-
ylation of K18 takes place. Following these events, K23 tor-regulated gene expression, and their coactivator po-
is acetylated, CARM1 associates with chromatin, and tential is dependent on an intact methyltransferase do-
methylation at R17 takes place. Exogenous expression main [13–18]. Histone H3 is the major in vivo substrate
of CBP is sufficient to drive the association of CARM1 for CARM1 methyltransferase activity, which preferen-
with chromatin and methylation of R17 in vivo, whereas tially methylates R17, and this process has been shown
an acetylase-deficient CBP mutant is unable to induce to be linked to gene activation [16, 19]. Interestingly,
these events. A mechanism for the observed coopera- CARM1 and CBP/p300 have been shown to cooperate
tion between acetylation and arginine methylation in transient transfection assays to enhance the tran-
comes from the finding that acetylation at K18 and K23, scriptional activation function of the estrogen receptor
but not K14, tethers recombinant CARM1 to the H3 tail [20], and this finding suggests the existence of a cross-
and allows it to act as a more efficient arginine methyl- talk between arginine methylation and lysine acetyla-
transferase. tion. Thus, histone arginine methylation seems to repre-
sent an activating step in gene transcription, but the
4 Correspondence: tk106@mole.bio.cam.ac.uk situation could be more complex since PRMT5, which
5 These authors have contributed equally to this work. is able to preferentially methylate H2A and H4 [21], has
6 Present address: Institute for Molecular Biology and Tumor Re- been linked to transcriptional repression via its methyl-
search (IMT), Philipps-University Marburg, Emil-Mannkopff-Str. 2,
transferase activity [11].35033 Marburg, Germany.
Given the many different types of modifications on7 Present address: 513 Parnassus Avenue, HSW 1119, University of
California, San Francisco, San Francisco, California 94143. histones, the question arises as to whether these are
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Figure 1. Ordered Modifications and Interplay between Arginine Methylation and Acetylation on Histone H3 in the pS2 Promoter
(A) Both nucleosomes in the proximal region of the pS2 promoter [26, 37], which do not move after estrogen induction, are represented (gray
circles). The positions of the pS2 primers used to amplify nucleosomal DNA, including the ER-responsive element (ERE), are shown.
(B) MCF-7 cells, without transfection () or 48 hr after transfection () with a wild-type or mutant (mut) CBP, were stimulated with vehicle
(time 0) or with 200 nM 17-estradiol (E2) for 15, 30, 60, and 180 min. Soluble chromatin was prepared and analyzed by chromatin immunoprecipi-
tation (ChIP) assays. Chromatin fragments were immunoprecipitated either with (a) anti-CARM1, (b) anti-CBP, (c) anti-Me-R17-H3, (d) anti-
Ac-K9 H3, (e) anti-Ac-K14 H3, (f) anti-Ac-K9/18 H3, or (g) anti-Ac-K23 H3 antibodies. As control antibodies, the (h) preimmune serum from
the rabbit, used for the anti-Me-R17-H3 antibody production, and (i) anti-Gal4DBD, used as an irrelevant antibody, were also used. Immunopreci-
tated chromatin was analyzed by quantitative PCR in the proximal pS2 promoter region (nt 159 to nt 463) [34].
(C) PCR analysis on input chromatin with the pS2 primers confirmed that equal chromatin amounts were used for ChIPs shown in (B).
(D) To determine if the events described in (B) are specific to an estrogen-responsive gene, (b) anti-Me-R17-H3 immunoprecipitates were
additionally analyzed for the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) promoter as a non-estrogen-regulated promoter by quanti-
tative PCR. The GAPDH primers are specific for the CpG island region [35]. (a) PCR analysis with the GAPDH primers on input chromatin
confirmed that equal chromatin amounts were used for ChIPs.
independently acting or whether they are interdepen- by CARM1. Acetylation of histone H3 by CBP stimulates
the tight association of CARM1 with chromatin anddent [13, 18, 22–24]. Evidence for a relationship between
modifications comes from the negative interference of methylation of R17 in vivo. Recombinant CARM1 binds
and methylates H3 more efficiently when H3 is acet-K9 H3 methylation by S10 H3 phosphorylation and the
stimulation of K14 H3 acetylation by S10 H3 phosphory- ylated, which provides a mechanism for the observed
cooperativity in vivo.lation [22–25]. Moreover, histone H4-R3 methylation fa-
cilitates p300-mediated acetylation [13], whereas H4
acetylation inhibits methylation by PRMT1. Although Results
these results suggest the existence of an interplay be-
tween histone modifications during transcription, the Acetylation of Lysine 18 in Histone H3 Appears
before Arginine 17 Methylation duringexistence of such crosstalk between acetylation and
arginine methylation has not yet been established in vivo. Estrogen-Regulated Transcription
We used chromatin immunoprecipitation (ChIP) analysisIn this report, we show an ordered recruitment of
lysine acetyltransferase and arginine methyltransferase to monitor the acetylation and methylation events that
occur on the endogenous pS2 gene (Figure 1A) followingactivities in vivo on the pS2 promoter, a process that
correlates closely with trancriptional activation. K18-H3 estrogen stimulation for 15, 30, 60, and 180 min (Figure
1B). At the same time points, the mRNA expression fromacetylation by CBP/p300 precedes R17-H3 methylation
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Figure 2. pS2 Gene Expression Is Prematurely Switched on and Enhanced by CBP Overexpression
mRNA steady-state levels of the pS2 gene were determined by Northern blot analysis. Total RNA was prepared from nontransfected () or
transfected () MCF-7 cells with wild-type CBP or acetylase-deficient CBP mutant (CBPmut), then stimulated with vehicle (time 0) or with
200 nM 17-estradiol (E2) for 15, 30, 60, and 180 min. A total of 10 g RNA per sample was resolved in a 1.2% formaldehyde-agarose gel
and was blotted onto a nylon membrane. The pS2 RNA was detected by hybridization with a 32P-labeled pS2 probe.
the pS2 gene was monitored (Figure 2). Four sets of 3). Within 30 min after estrogen stimulation, acetylation
of K23 is detected, CARM1 associates with chromatin,antibodies, including antibodies recognizing the en-
zymes CARM1 and CBP; an antibody recognizing meth- and R17 methylation takes place (Figures 1Ba, 1Bc, and
1Bg, lane 5). Methylation at R17 is further increased atylation at R17 of H3; antibodies recognizing acetylation
at K9, K14, K9/18, and K23 of H3; and control antibodies, 60 min postinduction, and this level is sustained at 180
min (Figure 1Bc, lanes 7 and 10). These results indicatewere used in the ChIP assays shown in Figure 1B. PCR
analysis on input chromatin with the pS2 primers con- that estrogen stimulation results in the ordered appear-
ance of modifications on the pS2 promoter: acetylationfirmed that equal chromatin amounts were used for im-
munoprecipitations (Figure 1C). by CBP takes place first and is followed by CARM1-
mediated methylation. During the course of estrogenFigure 1B shows that, in the absence of stimulation
(time 0), when only basal activity is detected from the signaling, the mRNA expressed from the pS2 gene is
increased (Figure 2), and this is consistent with previousgene (Figure 2, lane 1), the enzymes CARM1 and CBP are
not associated with the chromatin at the pS2 promoter findings that acetylation and methylation are coincident
with the active state of gene expression [16, 19, 26].(Figures 1Ba and 1Bb, lane 1). Analysis of modifications
reveals that only K14 acetylation can be detected under
noninduced conditions, whereas methylation at R17, or Acetylation by CBP Enhances Arginine 17
Methylation by CARM1 In Vivoacetylation at K9, K18, or K23, are not detectable (Fig-
ures 1Bc–1Bg, lane 1). K14 acetylation levels do not We next set out to establish if acetylation by CBP is
necessary for the stimulation of CARM1-mediated meth-change during the stimulation time course (Figure 1Be,
lanes 1, 3, 5, 7, and 10) and therefore seem not to be ylation or whether the ordered appearance of these two
modifications is unlinked. For this purpose, the CBPregulated by estrogen. Panel (d) of Figure 1B shows that
K9 acetylation is never detected on this promoter at any enzyme was transfected into MCF-7 cells. Panel (b),
lane 2 of Figure 1B shows that overexpressed CBP istime following stimulation with estrogen, even though
the Ac-K9 H3 antibody can detect acetylation at K9 on associated with the pS2 promoter in the absence of
estrogen induction. Expression of CBP induces the acet-the active, non-hormonal-regulated glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) promoter (data not ylation of K18 and K23 (Figures 1Bf and 1Bg, lane 2),
the stable association of CARM1 with chromatin, andshown). Consequently, the reactivity by the Ac-K9/18
H3 antibody shown in panel (f) of Figure 1B represents methylation of R17 (Figures 1Ba and 1Bc, lane 2). More-
over, CBP overexpression is sufficient to induce bythe acetylation events that take place on K18.
Following stimulation for 15 min with estrogen, CBP 2-fold the pS2 gene expression without estrogen stimu-
lation (Figure 2, lanes 1 and 2). After the addition ofis found to be associated with the pS2 promoter, and
acetylation of K18 appears (Figures 1Bb and 1Bf, lane estrogen, overexpression of CBP results in an increase
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Figure 3. Prior Acetylation of Histone H3 Augments CARM1 Methyltransferase Activity In Vitro
(A) Purified GST-p300 (1096–1721) or GST-p300 (1096–1721) HAT-deficient (p300m) proteins and recombinant histone H3 (2.5 g) were
incubated in IPH buffer in the presence of acetyl-CoA (10 M) for 1 hr to 30C. After acetylation, p300 was removed and CARM1 and
[14C-Me]S-adenosyl methionine were added and incubated for 1 hr at 30C. Reaction mixtures were resolved on SDS-PAGE and visualized
by autoradiography. Ponceaus staining shows that equal amounts of recombinant H3 were used in each reaction. The quantification of 14C
recombinant H3 in each reaction and in four different experiments shows a 2.5-fold increase of CARM1 activity when recombinant H3 was
previously acetylated by p300 and no increase in the case of the p300 HAT-deficient mutant.
(B) Purified GST-CARM1 protein was used in a protein methyltransferase assay on 2.5 g unmodified (aa 1–27), K14-acetylated (aa 1–27),
K18-acetylated (aa 1–27), or K23-acetylated (aa 1–27) H3 peptides in the presence of [3 H-Me]S-adenosyl methionine. Methylation of the
peptides was detected with a scintillation counter, and the average fold induction of CARM1 methylation activity compared to unmodified
H3 peptide from three different experiments is presented.
of the chromatin-bound CBP and CARM1, as well as Lysine 18 Acetylation Potentiates Arginine 17
Methylation by CARM1 In Vitrotheir corresponding modifications (Figures 1Ba, 1Bb,
1Bc, 1Bf, and 1Bg, lanes 3–8). These estrogen-stimu- Collectively, the in vivo analysis of the pS2 promoter
suggests that H3 acetylation by CBP augments methyla-lated events on the chromatin correlate closely with
higher levels of pS2 gene expression (Figure 2, lanes tion at R17 by CARM1. To provide direct evidence that
acetylation leads to increased methylation, we asked if3–11).
We next examined whether the stimulating effect of prior acetylation of histone H3 by p300 would augment
the methylation capacity of CARM1. Figure 3A showsCBP was dependent on its acetylase activity. Figure
1B shows that, when a CBP mutant compromised in that, indeed, p300-acetylated H3 acts as a better sub-
strate for CARM1, as suggested by the results of Xu etacetylase activity (CBPmut) is transfected, a further sta-
ble chromatin association of CARM1 is not observed al. [27]. We observed a distinct migration of histone H3
in the presence of p300 that was presumably due to a(compare lanes 8 and 9, panel [a]), stimulation of methyl-
ation and acetylation does not take place (compare conformational change as a result of acetylation.
In order to get further insight into the mechanismlanes 8 and 9, panels [a], [c], [e], [f], and [g]), and the
pS2 gene is not further activated, as seen after transfec- involved in the stimulating effect seen in vivo (Figure 1),
we sought to determine which of the CBP/p300 acetyla-tion with CBP wild-type (Figure 2, compare lanes 8 and
9). The inability of the CBPmut protein to induce these tion sites was important in stimulating CARM1 activity.
We therefore synthesized H3 tail peptides that wereevents is not due to its inability to bind chromatin since
it is associated with the promoter as efficiently as wild- acetylated at either K14, K18, or K23, each of which
are targets for CBP/p300 [28], and then asked if thesetype CBP (panel [b], lanes 8 and 9). We note that the
CBPmut does not induce a dominant-negative effect, acetylated peptides would act as a better substrate for
CARM1 methyltransferase activity. Figure 3B shows thatsuggesting that CBPmut is not in a large excess com-
pared to endogenous CBP. All of the changes in R17 prior acetylation of K18, and to a lesser extent K23,
increases the ability of CARM1 to methylate the H3 tailmethylation observed on the pS2 promoter are specific,
since methylation of R17-H3 on the active GAPDH gene peptide, whereas acetylation of K14 has a very modest
effect compared to the unmodified H3 tail. The substan-is not modulated either by estrogen or CBP overexpres-
sion (Figure 2D). tial augmentation of CARM1 activity by K18 acetylation
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Figure 4. Prior Acetylation of K18 and K23 in Histone H3 Peptides Increases the Affinity of CARM1 for Its Substrate
A total of 10 g of each coupled peptide was then incubated with purified GST-CARM1 in a methyltransferase assay for 15 min at 30C in
IPH buffer supplemented with 100 nM TSA. When indicated, 10 g free peptide competitors, including unmodified (UM), Ac-K18 (K18), and
Ac-K23 (K23) H3 peptides (aa 1–27), were added to the reaction at the same time as GST-CARM1. The reaction mixtures were then pelleted
by centrifugation, the supernatants were aspirated, and the beads were washed three times in IPH buffer. The binding products to the coupled
peptides were finally resolved by SDS-PAGE, blotted onto nitrocellulose, and analyzed by Western blot with an anti-CARM1 antibody.
fits well with the in vivo data in Figure 1 showing that involves increasing CARM1 interaction with its sub-
strate.acetylation of K18 appears prior to methylation of R17
on the pS2 promoter. These in vitro data provide a mech-
anistic explanation for the ordered appearance of these Discussion
modifications in vivo.
Acetylation of H3 may increase the enzymatic activity The results presented here demonstrate that activation
of the pS2 promoter by estrogen involves the specificof the CARM1 methyltransferase by increasing the affin-
ity of CARM1 for its substrate. To test this, we asked if ordered deposition of distinct modifications on histone
H3. Figure 5 summarizes these events. Under nonin-recombinant GST-CARM1 can bind the H3 tail more
effectively when H3 is acetylated. Figure 4 shows that duced conditions, the pS2 promoter is acetylated at
K14, but not at the other CBP/p300 target sites, K18 orGST-CARM1 binding to unmodified H3 peptide or to a
peptide acetylated at K14 is undetectable (compare K23 [28]. In addition, acetylation at K9 does not seem to
play a role in the regulation of this promoter by estrogen,lanes 2 and 3 to lane 1). In contrast, acetylation of K18
(Figure 4, lane 4) or K23 (lane 8) allows GST-CARM1 to since this site is not acetylated either before or after
estrogen addition.bind the H3 tail. In each of these cases, the acetyl-lysine
contributes to the affinity of CARM1, since K18- and Stimulation by estrogen (or transfection of CBP) re-
sults in the association of CBP and subsequentlyK23-acetylated peptides (but not an unmodified pep-
tide) can compete for the binding of CARM1 (Figure 4, CARM1 to the chromatin. The interaction with chromatin
is unlikely to be the sole mechanism by which theselanes 5, 6, and 7 and lanes 9, 10, and 11). These results
indicate that, at least partly, the mechanism by which enzymes are tethered to the promoter. Both CBP and
CARM1 have been shown to associate with promoter-acetylation of H3 augments CARM1 enzymatic activity
Figure 5. Model for the Ordered Histone H3
Modifications and Enzyme Recruitments at
the pS2 Promoter following Estrogen Stimu-
lation
Under noninduced conditions, the pS2 pro-
moter is acetylated at K14, but not at the other
CBP/p300 target sites, K18 or K23. Stimula-
tion by estrogen (or transfection of CBP) re-
sults in the association of CBP and subse-
quently CARM1 to the chromatin. Acetylation
of K18 (after 15 min) precedes the recruitment
of CARM1 and methylation at R17 and also
acetylation of K23 (after 30 min). K18 acetyla-
tion seems to increase the affinity of CARM1
for its substrate, which leads to better methyl-
transferase activity on R17. The appearance
of K23 acetylation could also be necessary
to increase and strengthen the association of
CARM1 with the histone H3 tail.
Acetylation Stimulates R17 Methylation by CARM1
2095
bound ER and its coactivator p160 [16, 19, 29]; so, the nent of the estrogen pathway (CBP) can switch on tran-
scription in the absence of estrogen (Figure 2, lanes 1tethering to chromatin is likely to be a subsequent step
that is necessary for the enzymatic activity to become and 2) indicates that components downstream of CBP
necessary for estrogen-stimulated expression of pS2manifest. In other words, binding of CBP and CARM1
to their substrate is necessary for the enzymatic activity, are not limiting. Such deregulated gene expression may
be relevant in certain cancers in which components ofand that crosslinking captures the enzyme-substrate
interaction during activation of transcription. this pathway are overexpressed [30].
The ordered deposition of modifications is a mecha-Acetylation of K18 precedes the recruitment of
CARM1 and methylation at R17 (Figure 5). Given that nism that may be employed to allow greater selectivity
of gene expression. There are certain general remarksK18 acetylation allows CARM1 to associate with histone
H3 tails and methylate them more effectively, the acet- that can be made regarding the events we see at the
pS2 promoter that may be applicable to many otherylation of K18 by CBP may be a prerequisite for
downstream CARM1 function. This argument is further genes whose activity is under the control of an external
stimulus. The first thing to say is that not all modifica-supported by CBP transfection experiments, which
demonstrate that CARM1 association with chromatin, tions that are possible on H3 are under the control of the
stimulus: acetylation of K14 is present before estrogenand methylation at R17, are not increased if the trans-
fected CBP is unable to acetylate histone H3. Together, addition and is not regulated by it. At the same time,
acetylation at K9 is not present either before or afterthese results provide a temporal recruitment and direct
dependence of arginine methylation on prior lysine acet- stimulation. There is, however, a specific set of modifica-
tions (Ac-K18, Ac-K23, and Me-R17) that is under theylation, which explains at least in part their cooperativity
in transcriptional activation. control of the stimulus, and these modifications seem
to be deposited in a specific order. This order may gen-Interestingly, our results show a dependency of these
events on the HAT activity of p300/CBP and present erate a unique environment on the chromatin, which
allows the recognition of specific proteins or results ina different picture than the one observed by Lee and
collaborators [17] in which they examined the coopera- the stimulation of certain enzymatic activities. Thus, the
pS2 gene may have a unique modification pattern on H3tive effect of the acetyltransferases P/CAF and p300
with CARM1 in transient transfections. They observe (as well as other histones), which dictates its chromatin
state and its gene expression pattern.that P/CAF cooperates with CARM1 in a HAT-dependent
manner, whereas p300 does not. The major site for The above concept, of specific modifications induced
by estrogen for the purposes of a coordinated regulationP/CAF acetylation is K14 on histone H3, whose acetyla-
tion levels do not change during estrogen stimulation of a subset of genes, could be applied to any signaling
pathway. If this would turn out to be the case, the detec-of the pS2 gene (Figure 1Be). We cannot exclude the
possibility that K14 acetylation plays some role in R17 tion of histone modification patterns on specific groups
of genes may be a useful means of detecting changesmethylation by CARM1, but, if it is the case, it appears
to be independent of the mechanism involving K18 and during differentiation, development, and the transition
of normal cells into the cancerous state.K23 acetylation described here at the pS2 gene. The
fact that Lee and collaborators see no need for the HAT
activity of p300 for cooperation may reflect the fact that Conclusions
their experiments were done under transient transfec- Our results provide a mechanistic link between the ob-
tion conditions and not on an ER-regulated promoter, served cooperativity of CBP and CARM1 on pS2 gene
which may explain that the mechanism is different to expression: CBP first acetylates K18 (and later K23),
the regulation of the endogenous ER-regulated pS2 pro- leading to CARM1 recruitment to the H3 tail, which stim-
moter, as reported here. ulates R17 methylation. This process is associated with
In vivo Ac-K23 only appears 30 min after E2 induction transcriptional activity. Thus, there exists crosstalk be-
and therefore appears slightly later than Ac-K18 (Figures tween lysine acetylation and arginine methylation of his-
1Bf and 1Bg, lanes 3 and 5). The precise role of this tones in vivo. Our results provide a mechanism for such
acetylation event is unclear. It does augment the binding crosstalk on H3 at a specific promoter in vivo and estab-
of CARM1 to H3 (Figure 4), which correlates with the lish a hierarchy of modifications for the implementation
further augmentations of R17 methylation (Figure 1Bc) of estrogen-regulated gene expression.
and transcriptional activity of the pS2 gene (Figure 2) at
Experimental Procedures60 min after estrogen stimulation. The coincidence of
K18 and K23 acetylation may be necessary for a tight
Antibodies, Plasmids, and Recombinant Proteinsassociation of CARM1 with chromatin, leading to opti-
The anti-Me-R17-H3 antibody has been described in [16] and is
mal methyltransferase and gene activities, but it may available from Abcam.com. The anti-Ac-K9 H3 antibody was pur-
also have additional functions. chased from Upstate, and the anti-Ac-K9/18 H3, -Ac-K14 H3, and
Interestingly, CBP expression is sufficient to trigger -Ac-K23 H3 antibodies have been described in [31]. The anti-CARM1
antibody was purchased from Upstate, and the anti-CBP (A22) anti-acetylation and methylation and can also induce pS2
body was purchased from Santa Cruz Biotechnologies.gene expression in the absence of estrogen. The further
The pRc/RSV-CBP with full-length CBP cDNA was a gift from R.effect of estrogen may be due to the more effective
Goodman, and the mutant CBPHAT cDNA fragment generated byrecruitment of CBP and CARM1 to the promoter or by
PCR and cloned into pRSV has been previously described [32]. The
the induction of additional modifications on chromatin, pGEX4T1-CARM1 plasmid was a gift from Michael Stallcup, and the
which are necessary for a full activation of the pS2 pro- GST-CARM1 fusion protein was expressed in and purified from E.
coli XA90 according to standard procedures.moter. The fact that overexpression of a single compo-
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Cell Culture and Transfections Campaign (SP2081-0104) and U.M.B. was funded by a Human Fron-
tiers Science Program grant (RG 25492).MCF-7 cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal calf serum at 37C and 5%
CO2. For transfection, MCF-7 cells were grown in phenol red-free Received: September 4, 2002
DMEM supplemented with 5% charcoal-dextran-stripped fetal calf Revised: October 8, 2002
serum for 3 days, and then transfected by using Fugene-6 according Accepted: October 10, 2002
to the protocol (Roche) with 5 g pRc/RSV-CBP or pRc/RSV- Published: December 23, 2002
CBPHAT. A total of 48 hr posttransfection, the cells were harvested
either for ChIP, RNA, or protein analysis. References
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